av/ipca--big.svg

COM:IPCA

Ipca Laboratories

  • Stock

Last Close

1,480.00

25/09 09:59

Market Cap

310.50B

Beta: -

Volume Today

540.70K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
32.47B
-
31.17B
4.02%
28.45B
8.70%
31.49B
10.69%
32.07B
1.82%
36.92B
15.14%
45.59B
23.47%
53.41B
17.16%
57.66B
7.97%
62.44B
8.29%
77.05B
23.39%
cost of revenue
11.85B
-
12.10B
2.11%
11.10B
8.28%
11.64B
4.90%
11.76B
1.04%
12.90B
9.71%
17.09B
32.43%
18.02B
5.44%
21.06B
16.88%
23.07B
9.52%
46.41B
101.23%
gross profit
20.62B
-
19.07B
7.53%
17.36B
8.97%
19.85B
14.38%
20.30B
2.27%
24.02B
18.29%
28.50B
18.65%
35.39B
24.19%
36.60B
3.43%
39.38B
7.58%
30.64B
22.20%
selling and marketing expenses
2.31B
-
2.45B
5.98%
2.14B
12.74%
2.60B
21.48%
2.53B
2.75%
2.94B
16.43%
3.32B
12.75%
2.99B
9.86%
3.70B
23.70%
5.56B
50.45%
general and administrative expenses
391.50M
-
485.50M
24.01%
487.90M
0.49%
578.40M
18.55%
808.10M
39.71%
799.40M
1.08%
585.80M
26.72%
970.70M
65.71%
736.50M
24.13%
761.90M
3.45%
selling general and administrative expenses
2.70B
-
2.94B
8.59%
2.63B
10.55%
3.18B
20.94%
3.33B
4.98%
3.74B
12.19%
3.90B
4.32%
3.96B
1.48%
4.43B
11.97%
6.32B
42.64%
22.25B
251.91%
research and development expenses
624.70M
-
402.60M
35.55%
404.60M
0.50%
416.80M
3.02%
266.20M
36.13%
207.40M
22.09%
313.80M
51.30%
523.80M
66.92%
418M
20.20%
461.30M
10.36%
other expenses
36M
-
28.40M
21.11%
16.20M
42.96%
24.20M
49.38%
191.50M
691.32%
210.70M
10.03%
201.90M
4.18%
144.80M
28.28%
155.70M
7.53%
1.26B
706.81%
cost and expenses
25.32B
-
27.47B
8.48%
26.67B
2.91%
28.84B
8.12%
29.23B
1.36%
31.57B
8.01%
38.14B
20.81%
40.20B
5.41%
47.04B
17.00%
55.79B
18.61%
68.67B
23.08%
operating expenses
13.47B
-
15.37B
14.08%
15.58B
1.32%
17.20B
10.41%
17.47B
1.58%
18.67B
6.87%
21.05B
12.77%
22.19B
5.39%
25.98B
17.09%
32.73B
25.97%
22.25B
32.00%
interest expense
216.10M
-
234.60M
8.56%
255M
8.70%
210.70M
17.37%
234.30M
11.20%
183M
21.90%
158.40M
13.44%
86.10M
45.64%
72.40M
15.91%
455.40M
529.01%
1.38B
203.62%
ebitda
7.54B
-
5.66B
24.90%
3.12B
44.88%
4.65B
48.88%
4.88B
4.97%
7.42B
52.06%
9.81B
32.26%
16.09B
63.99%
13.72B
14.73%
10.52B
23.28%
11.96B
13.60%
operating income
7.15B
-
3.69B
48.30%
1.78B
51.82%
2.66B
49.19%
2.84B
6.78%
5.31B
87.40%
7.42B
39.64%
13.15B
77.14%
10.59B
19.44%
7.03B
33.59%
8.38B
19.19%
depreciation and amortization
1.03B
-
1.80B
74.10%
1.72B
4.09%
1.73B
0.43%
1.78B
2.76%
1.82B
2.64%
2.10B
15.39%
2.09B
0.63%
2.32B
11.12%
2.62B
12.54%
3.57B
36.58%
total other income expenses net
-840M
-
-83.70M
90.04%
-627.10M
649.22%
47.40M
107.56%
69.40M
46.41%
150.10M
116.28%
-32.20M
121.45%
666.90M
2,171.12%
555M
16.78%
290M
47.75%
43.70M
84.93%
income before tax
6.31B
-
3.61B
42.74%
1.15B
68.07%
2.70B
134.45%
2.91B
7.48%
5.46B
88.09%
7.39B
35.21%
13.81B
86.94%
11.36B
17.78%
7.45B
34.38%
8.43B
13.07%
income tax expense
1.52B
-
1.02B
33.11%
185.70M
81.78%
675.20M
263.60%
511.10M
24.30%
1.04B
103.95%
1.35B
29.83%
2.40B
77.45%
2.25B
6.40%
2.53B
12.72%
3.13B
23.72%
net income
4.78B
-
2.59B
45.81%
967.30M
62.67%
2.03B
109.66%
2.39B
18.06%
4.45B
85.79%
6.06B
36.30%
11.40B
88.02%
8.84B
22.45%
4.71B
46.69%
5.47B
16.13%
weighted average shs out
252.40M
-
252.40M
0%
252.40M
0%
252.40M
0%
252.40M
0%
252.65M
0.10%
252.65M
0%
253.28M
0.25%
253.70M
0.17%
253.70M
0%
weighted average shs out dil
252.40M
-
252.40M
0%
252.40M
0%
252.40M
0%
252.42M
0.01%
252.65M
0.09%
252.88M
0.09%
253.28M
0.16%
253.70M
0.17%
253.70M
0%
eps
18.96
-
10.07
46.89%
3.69
63.36%
7.71
108.94%
9.49
23.09%
17.61
85.56%
24
36.29%
45.01
87.54%
34.85
22.57%
18.58
46.69%
21.57
16.09%
epsdiluted
18.96
-
10.07
46.89%
3.69
63.36%
7.71
108.94%
9.49
23.09%
17.61
85.56%
23.98
36.17%
45.01
87.70%
34.85
22.57%
18.58
46.69%
21.57
16.09%

All numbers in (except ratios and percentages)